Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET

Nature Medicine

Volumn 18, Issue 6, 2012, Pages 883-891

  Peinado, Héctor ^a   Alečković, Maša ^b   Lavotshkin, Simon ^c   Matei, Irina ^a   Costa Silva, Bruno ^a,d   Moreno Bueno, Gema ^e   Hergueta Redondo, Marta ^e   Williams, Caitlin ^a   García Santos, Guillermo ^a   Ghajar, Cyrus M ^f   Nitadori Hoshino, Ayuko ^a   Hoffman, Caitlin ^a   Badal, Karen ^a   Garcia, Benjamin A ^b   Callahan, Margaret K ^g   Yuan, Jianda ^g   Martins, Vilma R ^d   Skog, Johan ^h   Kaplan, Rosandra N ⁱ   Brady, Mary S ^g   Wolchok, Jedd D ^a,g   Chapman, Paul B ^a,g   Kang, Yibin ^b,j,k   Bromberg, Jacqueline ^a,g   Lyden, David ^g,k   more..

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b PRINCETON UNIVERSITY   (United States)

^c Columbia University ^*  (United States)

^d A C CAMARGO CANCER CENTER   (Brazil)

^e UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^f LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^h Exosome Diagnostics Inc   (United States)

ⁱ NATIONAL CANCER INSTITUTE   (United States)

^j RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^k Champalimaud Metastasis Programme   (Portugal)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; CD45 ANTIGEN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; ONCOPROTEIN; PROTEIN TYRP2; SCATTER FACTOR RECEPTOR; STEM CELL FACTOR; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 4;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXOSOME; FEMALE; GENE; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; METASTATIC MELANOMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RAB1A GENE; RAB27A GENE; RAB5B GENE; RAB7 GENE; RNA INTERFERENCE; TUMOR GROWTH;

ANIMALS; BONE MARROW CELLS; CELL LINE; EXOSOMES; FEMALE; HUMANS; MELANOMA; MICE; MICE, INBRED C57BL; PHENOTYPE; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MET; RAB GTP-BINDING PROTEINS; STEM CELLS;

MUS;

EID: 84862007577     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2753     Document Type: Article

References (58)

1. Théry, C., Zitvogel, L. & Amigorena, S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2, 569-579 (2002). (Pubitemid 37328732)
2. Iero, M. et al. Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ. 15, 80-88 (2008). (Pubitemid 350286175)
3. Ratajczak, J., Wysoczynski, M., Hayek, F., Janowska-Wieczorek, A. & Ratajczak, M.Z. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20, 1487-1495 (2006). (Pubitemid 44264090)
4. Cocucci, E., Racchetti, G. & Meldolesi, J. Shedding microvesicles: artefacts no more. Trends Cell Biol. 19, 43-51 (2009).
5. Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659 (2007). (Pubitemid 47214727)
6. van Niel, G., Porto-Carreiro, I., Simoes, S. & Raposo, G. Exosomes: a common pathway for a specialized function. J. Biochem. 140, 13-21 (2006). (Pubitemid 44433541)
7. Peinado, H., Lavotshkin, S. & Lyden, D. The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin. Cancer Biol. 21, 139-146 (2011).
8. Ratajczak, J. et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20, 847-856 (2006).
9. Nazarenko, I. et al. Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res. 70, 1668-1678 (2010).
10. Webber, J., Steadman, R., Mason, M.D., Tabi, Z. & Clayton, A. Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res. 70, 9621-9630 (2010).
11. Liu, Y. et al. Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells. Am. J. Pathol. 176, 2490-2499 (2010).
12. Xiang, X. et al. Induction of myeloid-derived suppressor cells by tumor exosomes. Int. J. Cancer 124, 2621-2633 (2009).
13. Al-Nedawi, K. et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat. Cell Biol. 10, 619-624 (2008). (Pubitemid 351627382)
14. Hao, S. et al. Epigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes. Exp. Oncol. 28, 126-131 (2006). (Pubitemid 44140264)
15. Skog, J. et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10, 1470-1476 (2008).
16. Sethi, N. & Kang, Y. Unravelling the complexity of metastasis-molecular understanding and targeted therapies. Nat. Rev. Cancer 11, 735-748 (2011).
17. Psaila, B. & Lyden, D. The metastatic niche: adapting the foreign soil. Nat. Rev. Cancer 9, 285-293 (2009).
18. Kaplan, R.N. et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820-827 (2005). (Pubitemid 41753060)
19. Gao, D. et al. Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression. Biochim. Biophys. Acta 1796, 33-40 (2009).
20. Erler, J.T. et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15, 35-44 (2009).
21. Hiratsuka, S., Watanabe, A., Aburatani, H. & Maru, Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 8, 1369-1375 (2006). (Pubitemid 44835111)
22. Hood, J.L., San, R.S. & Wickline, S.A. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res. 71, 3792-3801 (2011).
23. Jung, T. et al. CD44v6 dependence of premetastatic niche preparation by exosomes. Neoplasia 11, 1093-1105 (2009).
24. Trusolino, L., Bertotti, A. & Comoglio, P.M. MET signalling: principles and functions in development, organ regeneration and cancer. Nat. Rev. Mol. Cell Biol. 11, 834-848 (2010).
25. Stella, G.M., Benvenuti, S. & Comoglio, P.M. Targeting the MET oncogene in cancer and metastases. Expert Opin. Investig. Drugs 19, 1381-1394 (2010).
26. Boccaccio, C. & Comoglio, P.M. Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat. Rev. Cancer 6, 637-645 (2006). (Pubitemid 44140861)
27. Cecchi, F., Rabe, D.C. & Bottaro, D.P. Targeting the HGF/Met signalling pathway in cancer. Eur. J. Cancer 46, 1260-1270 (2010).
28. Peruzzi, B. & Bottaro, D.P. Targeting the c-Met signaling pathway in cancer. Clin. Cancer Res. 12, 3657-3660 (2006). (Pubitemid 44000247)
29. Birchmeier, C., Birchmeier, W., Gherardi, E. & Vande Woude, G.F. Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 4, 915-925 (2003).
30. Stenmark, H. Rab GTPases as coordinators of vesicle traffic. Nat. Rev. Mol. Cell Biol. 10, 513-525 (2009).
31. Ostrowski, M. et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol. 12, 19-30 (2009).
32. Braeuer, R.R., Zigler, M., Villares, G.J., Dobroff, A.S. & Bar-Eli, M. Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment. Semin. Cancer Biol. 21, 83-88 (2011).
33. Fidler, I.J. Critical determinants of melanoma metastasis. J. Investig. Dermatol. Symp. Proc. 1, 203-208 (1996). (Pubitemid 126759366)
34. Grammatikakis, N. et al. The role of Hsp90N, a new member of the Hsp90 family, in signal transduction and neoplastic transformation. J. Biol. Chem. 277, 8312-8320 (2002). (Pubitemid 34968291)
35. Fidler, I.J. & Nicolson, G.L. Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines. J. Natl. Cancer Inst. 57, 1199-1202 (1976).
36. Huang, Y. et al. Pulmonary vascular destabilization in the premetastatic phase facilitates lung metastasis. Cancer Res. 69, 7529-7537 (2009).
37. Hiratsuka, S. et al. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat. Cell Biol. 10, 1349-1355 (2008).
38. Lucas, R., Verin, A.D., Black, S.M. & Catravas, J.D. Regulators of endothelial and epithelial barrier integrity and function in acute lung injury. Biochem. Pharmacol. 77, 1763-1772 (2009).
39. Joyce, J.A. & Pollard, J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9, 239-252 (2009).
40. Balaj, L. et al. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat. Commun. 2, 180 (2011).
41. Taylor, D.D., Taylor, C.G., Jiang, C.G. & Black, P.H. Characterization of plasma membrane shedding from murine melanoma cells. Int. J. Cancer 41, 629-635 (1988).
42. Zöller, M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat. Rev. Cancer 11, 254-267 (2011).
43. Jalili, A., Shirvaikar, N., Marquez-Curtis, L.A., Turner, A.R. & Janowska-Wieczorek, A. The HGF/c-Met axis synergizes with G-CSF in the mobilization of hematopoietic stem/progenitor cells. Stem Cells Dev. 19, 1143-1151 (2010).
44. Tesio, M. et al. Enhanced c-Met activity promotes G-CSF-induced mobilization of hematopoietic progenitor cells via ROS signaling. Blood 117, 419-428 (2011).
45. Lima, L.G., Chammas, R., Monteiro, R.Q., Moreira, M.E. & Barcinski, M.A. Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner. Cancer Lett. 283, 168-175 (2009).
46. Logozzi, M. et al. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS ONE 4, e5219 (2009).
47. Guise, T. Examining the metastatic niche: targeting the microenvironment. Semin. Oncol. 37 (suppl. 2), S2-S14 (2010).
48. Aliotta, J.M. et al. Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription. Exp. Hematol. 38, 233-245 (2010).
49. Aliotta, J.M. et al. Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation. Stem Cells 25, 2245-2256 (2007). (Pubitemid 47480483)
50. Oskarsson, T. et al. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat. Med. 17, 867-874 (2011).
51. Psaila, B., Kaplan, R.N., Port, E.R. & Lyden, D. Priming the 'soil' for breast cancer metastasis: the pre-metastatic niche. Breast Dis. 26, 65-74 (2006). (Pubitemid 46647415)
52. Ewing, J. Neoplastic Diseases: A Treatise on Tumours, 3rd edn. (W.B. Saunders Co., Philadelphia, 1928).
53. Paget, G. The distribution of secondary growths in cancer of the breast. Lancet 133, 571-573 (1889).
54. Scott, K.L. et al. Proinvasion metastasis drivers in early-stage melanoma are oncogenes. Cancer Cell 20, 92-103 (2011).
55. Christensen, J.G., Burrows, J. & Salgia, R. c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention. Cancer Lett. 225, 1-26 (2005). (Pubitemid 40732764)
56. Akavia, U.D. et al. An integrated approach to uncover drivers of cancer. Cell 143, 1005-1017 (2010).
57. Wang, J.S., Wang, F.B., Zhang, Q.G., Shen, Z.Z. & Shao, Z.M. Enhanced expression of Rab27A gene by breast cancer cells promoting invasiveness and the metastasis potential by secretion of insulin-like growth factor-II. Mol. Cancer Res. 6, 372-382 (2008).
58. Hendrix, A. et al. Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis. J. Natl. Cancer Inst. 102, 866-880 (2010).